Same-day discharge is not inferior to longer length of in-hospital stay for 90-day readmissions following shoulder arthroplasty.

BACKGROUND: Shoulder arthroplasty is a common orthopedic procedure, performed historically in the inpatient setting. However, interest in same-day discharge has increased. We sought to evaluate 90-day readmission, 90-day emergency department (ED) visit, 90-day deep infection, 90-day venous thromboembolism (VTE), and 1-year mortality after same-day shoulder arthroplasty compared with an inpatient stay. METHODS: We conducted a retrospective cohort study using data from an integrated health care system's Shoulder Arthroplasty Registry. A total of 6503 elective primary unilateral total shoulder and reverse total shoulder arthroplasties performed between 2005 and 2016 were included; 405 (6%) had same-day discharge. The likelihood of 90-day events, including readmission, ED visit, deep infection, and VTE, and 1-year mortality after same-day discharge was compared with 1- to 4-night inpatient stay using generalized estimating equations with noninferiority testing, adjusting for age, sex, body mass index, race, American Society of Anesthesiologists classification, select comorbidities, osteoarthritis, anesthesia type, procedure type, and surgeon effect. RESULTS: We failed to observe a difference between same-day discharge and 1- to 4-night stay in terms of 90-day readmission, 90-day ED visit, and 1-year mortality. Same-day discharge was not inferior to 1- to 4-night stay regarding 90-day readmission, but we did not have evidence to support noninferiority for 90-day ED visits or 1-year mortality. Ninety-day deep infections and VTE were too infrequent for adjusted analysis. CONCLUSIONS: We found same-day shoulder arthroplasty not to be inferior to an inpatient stay for 90-day readmission. Future investigation into the reasons for readmission and ED visit after same-day shoulder arthroplasty and interventions to mitigate these adverse events is needed.

Fixation methods and implants in shoulder stabilization: A historical perspective.

BACKGROUND: Treatment for shoulder instability has changed significantly over the past decade from open procedures to arthroscopic procedures using a variety of different fixation methods and implants. The development of these implants has been highly influenced by the numerous complications that have arisen using early designs. METHODS: A review of the literature was performed to describe the history of shoulder stabilization. CONCLUSION: As biomedical technology improves, we should continue to see changes to implant design and manufacturing. Having an understanding of the history and evolution of these implants will provide us with context in which to guide future implant design and clinical use. This review article provides a comprehensive overview of the evolution of early shoulder stabilization techniques and implants to the modern implants being used today.

Analysis of glenoid inter-anchor distance with an all-suture anchor system.

BACKGROUND: All-suture anchors used in arthroscopic shoulder stabilization employ small diameter anchors, which allow greater placement density on narrow surfaces such as the glenoid. There is no consensus in the literature about how close to one another two anchors may be implanted. PURPOSE: The purpose of the present study is to compare the strength characteristics of two all-suture anchors placed in cadaveric human glenoid at variable distances to one another, in order to determine the minimum distance required for optimal strength. METHODS: Twelve fresh-frozen human cadaveric glenoids were implanted with 1.4 mm all-suture anchors at varying inter-anchor distances. Each glenoid was used for four tests, for a total of 48 tests. Anchors were implanted adjacent to one another or with 2, 3, or 5 mm bone bridges between pilot holes. The glenoids then underwent pullout testing using a test frame with a 5N preload followed by displacement of 12.5 mm/s. The primary outcomes were stiffness, failure strength, and ultimate strength. RESULTS: Stiffness was 13.52 ±â€¯3.8, 17.97 ±â€¯5.02, 17.59 ±â€¯4.65 and 18.95 ±â€¯4.67 N/mm for the adjacent, 2, 3, and 5 mm treatment groups, respectively. The adjacent group had a significantly lower stiffness compared to the other treatment groups. Failure strength was 48.68 ±â€¯20.64, 76.16 ±â€¯23.78, 73.19 ±â€¯35.83 and 87.04 ±â€¯34.67 N for the adjacent, 2, 3, and 5 mm treatment groups, respectively. The adjacent group had a significantly lower failure strength compared to the other treatment groups. Ultimate strength was also measured to be 190.59 ±â€¯140.93, 268.7 ±â€¯115.1, 283.23 ±â€¯118.43, and 291.28 ±â€¯118.24 for the adjacent, 2, 3, and 5 mm treatment groups, respectively. CONCLUSIONS: This biomechanical study provides evidence that 1.4 mm all-suture anchors demonstrate similar strength characteristics when placed at least 2 mm or greater from one another. When 1.4 mm all-suture anchors were placed adjacent to one another, there was an observed decrease in failure strength and stiffness. CLINICAL RELEVANCE: This study suggests that 1.4 mm all-suture anchors may be placed as close as 2 mm to one another while preserving strength characteristics.

Effects of local anesthetics on articular cartilage.

BACKGROUND: Recent basic science studies have demonstrated local anesthetic chondrotoxicity in vivo and in vitro in both human and animal cartilage. Clinically, chondrolysis associated with the use of intra-articular local anesthetic pain pumps has been described by several groups. This has raised concern regarding the clinical use of intra-articular local anesthetics. METHODS: The authors undertook a review of the current orthopaedic literature on local anesthetic chondrotoxicity and its potential relationship to clinical chondrolysis. RESULTS: Local anesthetics such as bupivacaine, lidocaine, and ropivacaine are chondotroxic to human articular cartilage in vitro, although ropivacaine is less so. The evidence suggests that there is a greater risk for chondrolysis with a longer exposure to a higher concentration of local anesthetic, such as with a pain pump, than with a single injection. However, late cellular and metabolic changes are seen after even a single injection of bupivacaine in animal models, and the loss of an intact cartilage matrix also leads to more extensive chondrocyte death. Some studies suggest that additives and the pH of the local anesthetic solution may also play a role in chondrotoxicity. CONCLUSION: Intra-articular local anesthetics should be used with caution, especially continuous infusions of bupivacaine and lidocaine at high concentrations in joints with compromised cartilage. The consequences of a single intra-articular injection of local anesthetic remains unclear and requires further investigation. CLINICAL RELEVANCE: Intra-articular use of local anesthetics may have lasting detrimental effects on human articular cartilage and chondrocytes, although the clinical relationship between local anesthetic exposure and chondrolysis requires further study.